3rd Quarter - Report

SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$430,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to patient access to treatments Issues related to rare diseases such as Duchenne Muscular Dystrophy Issues related to newborn screening for rare diseases

LobbyistCovered position, as disclosed
KIP PAYNE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues related to the Inflation Reduction Act's prescription drug provisions

LobbyistCovered position, as disclosed
KIP PAYNE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Issues related to scientific innovation in healthcare such as gene therapies Issues related to artificial intelligence and data governance

LobbyistCovered position, as disclosed
CAROLYN HICKEY —
KIP PAYNE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax issues related to research and development

LobbyistCovered position, as disclosed
KIP PAYNE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.